Please enable JS

ABOUT US


About Silicon Genomics

Silicon Genomics is a strategic research and experimentation initiative of a small cadre of innovators that recognize the scientific, technological and economic value of a shared, neuromorphic, cloud-based, high performance computing capability.

Silicon Genomics is strategically positioned at the intersection of computer science and the life sciences. At our inception, we took a leap from the application of computing to support scientists "do" science (i.e. "computational science") to the integration of computer science concepts, tools and theorems into the very fabric of science.

Silicon Genomics is leading innovation in the field of insilico drug discovery optimization and will advance the current state of high performance neuromorphic scientific computing for institutions engaged in functional genomics and other computationally intensive drug discovery activities.

The project is tapping the power of scientific discovery and technological innovation to advance the practice of insilico discovery in order to dramatically improve the quality of people's lives.

Silicon Genomics is pioneering the development of novel applications of insilico discovery and designing the industry's first fully validated High Performance Neuromorphic Cloud Computing platform dedicated exclusively to drug discovery. The company will set the performance standard for insilico scientific discovery and innovation.

We are an entrepreneurial, science-focused, technology-based enterprise dedicated to helping scientists identify the causes and find cures for serious illness. Our goal is to dramatically improve people's lives by providing researchers with the tools to identify the cause of disease and to develop innovative therapeutics.

Our Mission includes the following strategic goals:

  • Enhance Discovery Performance
  • Optimize Research Risk Management
  • Increase Execution Succes
  • Mitigate Research Risk Costs

Silicon Genomics Cloud-based insilico drug discovery optimization platform, NeuroGen, will place us at the forefront of large-scale computational modeling capabilities in the fields of Genomics and Proteomics.

Silicon Genomics is developing novel applications to address problems of interest to science and society.